Vivek Ramaswamy Quotes

New drugs and surgical techniques offer promise in the fight against cancer, Alzheimer's, tuberculosis, AIDS, and a host of other life-threatening diseases. Animal research has been, and continues to be, fundamental to advancements in medicine.

More important is the fact that embryonic stem cell research could lead to new treatments and cures for the many Americans afflicted with life-threatening and debilitating diseases.

We now have the ability to explore many new treatments for many diseases. However we do not have enough money to explore them all…. I measure time by the number of patients who die each day as the result of diseases that we do not have enough money to develop cures for. We have the tools. We need the money.

Scientists have established huge numbers of links between particular diseases and snippets of DNA, but in the great majority of cases, this has not yet been translated into treatments that can help cure patients. These treatments will come - tomorrow, or the day after.

Research is what it's going to take to cure all these diseases.

We have a responsibility to promote stem cell research which could lead to treatments and cures for diseases affecting millions of Americans.

Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies.

I'd like to focus on my life on creating new medicines for people who are suffering from rare disease.

My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson's diseases, diabetes or blood diseases.

Dedicated researchers seek better treatments and cures for diabetes, kidney disease, Alzheimer's and every form of cancer. But these scientists face an array of disincentives. We can do better.

Affordability is critical so that patients have access to medicines. At the same time, it's also important that we have the kind of incentives that allow us to do the kinds of studies that we need to do to go after these diseases like Alzheimer's.

We'll be investing in basic science research with the goal of curing disease.

Once an effective drug is approved to treat a deadly condition, introducing a second drug to treat the same disease can be hard. It's tough to recruit patients with a debilitating disease for a clinical trial when a proven medicine is already available.

Patients with fatal diseases are fighting for their lives every day while real, meaningful, life-extending treatments sit on the shelf just beyond their reach.

Practically every day, there is a story in the newspapers about a new breakthrough drug on Parkinson's.

Society as a whole is better off when information is available to the public. Whether you are talking about how to prevent disease, or about who does the best job of treating disease, it is useful to provide as much information to the public as possible.

Medical science has proven time and again that when the resources are provided, great progress in the treatment, cure, and prevention of disease can occur.

There's always going to be the need for new medications, better medications.

Although there have been warnings that it was coming for years, the Alzheimer's epidemic is here now and millions more families will be touched by this progressive - and ultimately fatal - disease unless its course can be altered.

Throughout my career, as both a physician and a scientist, I have drawn inspiration from Merck's unwavering commitment to scientific excellence. Over time, this commitment has brought forth an unparalleled number of breakthrough medicines and vaccines that improve the lives of patients around the world.

In Wisconsin, We're at the forefront of research that might one day bring cures for diseases like Parkinsons and Alzheimers, and we must seize its great potential.

Stem cell research holds out the promise of finding cures and treatments for a wide range of diseases.

The medicines of today are based upon thousands of years of knowledge accumulated from folklore, serendipity and scientific discovery. The new medicines of tomorrow will be based on the discoveries that are being made now, arising from basic research in laboratories around the world.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

If my dramatic career doesn't work out, I will go on to research and find cures for Alzheimer's or Parkinson's and other motor neuron diseases. It's a very exciting field of research. But I'd like to continue in drama, so it wouldn't be very smart of me if I blew this amazing opportunity with an inappropriate lifestyle.